Tecfidera cleans up

Biogen Idec Inc. (NASDAQ:BIIB) added $3.7 billion to its market cap after FDAapproved Tecfidera dimethyl fumarate with the cleanest label among oral MS drugs.

Doctors have told BioCentury they like the safety advantage of Tecfidera (BG-12) after Phase III studies showed flushing and abdominal pain as the most common serious adverse events (see BioCentury, April 18, 2011)...